pHLIP-mediated Targeting of Truncated Tissue Factor to Tumor Vessels Causes Vascular Occlusion and Impairs Tumor Growth

Oncotarget - United States
doi 10.18632/oncotarget.4395
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Dual Targeting of Vascular Endothelial Growth Factor and Bone Morphogenetic Protein-9/10 Impairs Tumor Growth Through Inhibition of Angiogenesis

Cancer Science
Cancer ResearchMedicineOncology
2017English

Distribution of Vascular Permeability Factor (Vascular Endothelial Growth Factor) in Tumors: Concentration in Tumor Blood Vessels

Journal of Experimental Medicine
MedicineAllergyImmunology
1991English

Measuring Tumor Aggressiveness and Targeting Metastatic Lesions With Fluorescent pHLIP

Molecular Imaging and Biology
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2010English

Predictive Model of Thrombospondin-1 and Vascular Endothelial Growth Factor in Breast Tumor Tissue

npj Systems Biology and Applications
GeneticsMolecular BiologyBiochemistryApplied MathematicsSimulationComputer Science ApplicationsModelingDrug Discovery
2016English

Inhibition of Vascular Endothelial Growth Factor (VEGF) Signaling in Cancer Causes Loss of Endothelial Fenestrations, Regression of Tumor Vessels, and Appearance of Basement Membrane Ghosts

American Journal of Pathology
Forensic MedicinePathology
2004English

Prognostic Value of Carcinoembryonic Antigen and Vascular Endothelial Growth Factor Tumor Tissue Content in Colorectal Cancer

Oncology
MedicineCancer ResearchOncology
2006English

Vascular Endothelial Growth Factor Receptor-2-Mediated Mitogenesis Is Negatively Regulated by Vascular Endothelial Growth Factor Receptor-1 in Tumor Epithelial Cells

American Journal of Pathology
Forensic MedicinePathology
2001English

Nanotechnology-Mediated Targeting of Tumor Angiogenesis

Vascular Cell
Computer NetworksDevelopmental NeuroscienceNeurologyCell BiologyCommunications
2011English

Circulating Endothelial Progenitors and Tumor Resistance to Vascular-Targeting Therapies

Cancer Discovery
Oncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy